Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2011 by Northwestern University.
Recruitment status was  Active, not recruiting
Information provided by:
Northwestern University Identifier:
First received: August 4, 2004
Last updated: April 11, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2012
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)